Genomic Vision appoints Mark David Lynch as Global Commercial and Marketing Director
BAGNEUX, France (BUSINESS WIRE) Regulatory News:
Genomic Vision
(Paris:GV)
(the “Company” - FR0011799907 – GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, today announces the appointment of Mark David Lynch as Global Commercial and Marketing Director.
Graduated in microbiology from University of Glasgow, Mark David Lynch has extensive experience in the business development of research and diagnostic devices.
Prior to joining Genomic Vision, Mark spent nearly 10 years at Fluidigm Corporation, a US biotechnology company, where he held different senior management positions, before becoming Head of Sales & Support. He was instrumental in the Company’s expansion, with substantial contribution to the growth of its microfluids business in the US market in 2020. During his career at Fluidigm,
Forsythoside A- potential treatment for diabetic nephropathy
dovepress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dovepress.com Daily Mail and Mail on Sunday newspapers.
TCEB3 in the progression of cervical cancer
dovepress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dovepress.com Daily Mail and Mail on Sunday newspapers.